Baxter International Pharmaceuticals revenue
Pharmaceuticals revenue at Baxter International came to $621.0M for the quarter to 31 Mar 2026, up 6.9% from a year earlier.
As Baxter International reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 30 Apr 2026.
By quarter
| Period ending | Pharmaceuticals revenue | Change on a year | Filed |
|---|---|---|---|
| 31 Mar 2026 | $621.0M | up 6.9% | 30 Apr 2026 |
| 31 Dec 2025 | $668.0M | up 3.9% | 12 Feb 2026 |
| 30 Sep 2025 | $632.0M | up 7.5% | 4 Nov 2025 |
| 30 Jun 2025 | $612.0M | up 1.7% | 5 Aug 2025 |
| 31 Mar 2025 | $581.0M | up 0.5% | 6 May 2025 |
| 31 Dec 2024 | $643.0M | up 7.7% | 21 Feb 2025 |
| 30 Sep 2024 | $588.0M | up 1.4% | 12 Nov 2024 |
| 30 Jun 2024 | $602.0M | up 9.5% | 6 Aug 2024 |
| 31 Mar 2024 | $578.0M | up 10.5% | 2 May 2024 |
| 31 Dec 2023 | $597.0M | — | 8 Feb 2024 |
| 30 Sep 2023 | $580.0M | up 10.5% | 2 Nov 2023 |
| 30 Jun 2023 | $550.0M | — | 27 Jul 2023 |
| 31 Mar 2023 | $523.0M | — | 27 Apr 2023 |
| 30 Sep 2022 | $525.0M | — | 27 Oct 2022 |
Definition
Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.
Other operating KPIs of Baxter International: Infusion Therapies & Platforms revenue · Infusion Therapies & Technologies revenue · Care & Connectivity Solutions revenue · Advanced Surgery revenue · Drug Compounding revenue · Front Line Care revenue · Injectables & Anesthesia revenue · Medical Products & Therapies revenue · Healthcare Systems & Technologies revenue · United States revenue · International revenue · financial statements
Every KPI and segment of BAX, in the terminal.
Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.
